Medicines and Recovery Plan Notices




NEW ZEALAND GAZETTE, No. 126 — 19 NOVEMBER 2015

Product:
Viagra
Active Ingredient:
Sildenafil citrate 35.112mg equivalent to Sildenafil 25mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturers:
Pfizer Australia Pty Limited, West Ryde, Australia
Fareva Amboise, Poce Sur Cisse, France

Product:
Viagra
Active Ingredient:
Sildenafil citrate 70.225mg equivalent to Sildenafil 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturers:
Pfizer Australia Pty Limited, West Ryde, Australia
Fareva Amboise, Poce Sur Cisse, France

Product:
Viagra
Active Ingredient:
Sildenafil citrate 140.45mg equivalent to Sildenafil 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturers:
Pfizer Australia Pty Limited, West Ryde, Australia
Fareva Amboise, Poce Sur Cisse, France

Product:
Vivera
Active Ingredient:
Sildenafil citrate 35.112mg equivalent to Sildenafil 25mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturers:
Pfizer Australia Pty Limited, West Ryde, Australia
Fareva Amboise, Poce Sur Cisse, France

Product:
Vivera
Active Ingredient:
Sildenafil citrate 70.225mg equivalent to Sildenafil 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturers:
Pfizer Australia Pty Limited, West Ryde, Australia
Fareva Amboise, Poce Sur Cisse, France

Product:
Vivera
Active Ingredient:
Sildenafil citrate 140.45mg equivalent to Sildenafil 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturers:
Pfizer Australia Pty Limited, West Ryde, Australia
Fareva Amboise, Poce Sur Cisse, France

Dated this 13th day of November 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2015-go6776

Lyttelton Port Recovery Plan Commencement Notice

Pursuant to section 21(4) of the Canterbury Earthquake Recovery Act 2011, the Minister for Canterbury Earthquake Recovery gives the following notice.

Notice

  1. Title—This notice is the Lyttelton Port Recovery Plan Commencement Notice.

  2. Commencement—The Lyttelton Port Recovery Plan is issued and comes into effect on 19 November 2015.

  3. Inspection—The Lyttelton Port Recovery Plan is available on the Canterbury Earthquake Recovery Authority’s website
    www.cera.govt.nz

Reference copies of the Lyttelton Port Recovery Plan will be available at the Canterbury Earthquake Recovery Authority’s Office at Level 8, HSBC Tower, 62 Worcester Boulevard, Christchurch, and at Christchurch City, Selwyn District and Waimakariri District Councils offices, main service centres and libraries.

Dated at Wellington this 19th day of November 2015.

110



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 126





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
13 November 2015
Medicines, Distribution consent, Medicines Act 1981, Viagra, Vivera, Sildenafil citrate
  • Chris James, Acting Group Manager, Medsafe, Ministry of Health

🚨 Lyttelton Port Recovery Plan Commencement Notice

🚨 Emergency Management
19 November 2015
Lyttelton Port, Recovery Plan, Canterbury Earthquake Recovery Act 2011, Commencement
  • Minister for Canterbury Earthquake Recovery